5-BROMO-4-FLUORO-1-(TRIISOPROPYLSILANYL)-7-AZAINDOLE, 95.0%, 100mg

Spacers for Sequencing Electrophoresis Unit, 0.35 mm, 1 Pair

Boc-(S)-3-thienylglycine, 99.0%, 250mg

2-(2-{[(benzyloxy)carbonyl]amino}-6-oxo-6,9-dihydro-1H-purin-9-yl)acetic acid, 98%, 100mg

1,3-Dichloro-2-nitrobenzene>98.0%(GC)25g

(3R,6R)-3,6-Octanediol>96.0%(GC)500mg

1-(1,3-dimethyl-1H-pyrazol-4-yl)ethanone hydrate, 95.0%, 1g

6,7-Dimethoxy-3,4-dihydroisoquinoline, 95.0%, 100g

(5-Bromo-1-methyl-1H-pyrazol-4-yl)methanol, 95.0%, 5g

4,4'-Oxybis(phenoxybenzene)>98.0%(HPLC)1g

N-(14-Amino-3,6,9,12-tetraoxatetradecyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95%, 250mg

2-(PYRIDIN-4-YL)OXAZOLE, 93.0%, 500mg

2,4-Dichloro-3,6-dimethylpyridine, 95.0%, 1g